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TO DISCIPLINE OR NOT TO DISCIPLINE: A
FRAMEWORK FOR NEW MEXICO TO ANALYZE
THE ETHICS OF MEDICAL MARIJUANA
REPRESENTATION
Jesse Montoya*

INTRODUCTION
Complex regulatory schemes in many states, including New Mexico, create
a “legal minefield” for producers of medical marijuana.1 This regulatory minefield
is far-reaching and can present business owners with an array of legal issues
including problems with local law enforcement,2 obtaining capital, navigating
commercial real-estate deals, planning distribution channels, and other ordinary
business needs.3 Producers of medical marijuana must navigate this legal and
regulatory minefield in order to operate their businesses.4 Worst of all, in many
states, like New Mexico, medical marijuana producers must perform these legal
gymnastics—sometimes without access to an attorney.5 In New Mexico, lawyers are
hamstrung by the interpretation of ethical rules forbidding lawyers from “assisting”
legal producers of medical marijuana.6 Compounding the confusion, the exact

* University of New Mexico School of Law, Class of 2018. Thanks to Professors Walker Boyd and
Robert Desiderio for their assistance with this Note. I am also indebted to Kyle Duffy for his patience and
excellence in editing.
1. See Erwin Chemerinsky et al., Cooperative Federalism and Marijuana Regulation, 62 UCLA L.
REV. 74, 97 (2015).
2. See Michael Berkey, Mary Jane’s New Dance: The Medical Marijuana Legal Tango, 9 CARDOZO
PUB. L. POL’Y & ETHICS J. 417, 438–39 (2011).
3. See Ian Wagemaker, Professional Ethics—The High Risk of Going Green: Problems Facing
Transactional Attorneys and the Growth of the State-Level Legal Marijuana Industries, 37 W. NEW ENG.
L. REV. 371, 399 (2015).
4. See id.; see also Ian S. Clement, Representation in Marijuana Industry Chilled by Ethics Rules,
A.B.A. LITIGATION NEWS (May 2, 2016), https://apps.americanbar.org/litigation/litigationnews/top_
stories/050216-marijuana-ethics-rules.html.
5. See Chemerinsky et al., supra note 1, at 95, 97 (“One of the biggest obstacles facing marijuana
businesses is finding attorneys who are willing to provide them with legal services. . . . [Medical
marijuana businesses] may or may not be able to secure legal representation to help them through the legal
minefield created by complex state regulatory apparatuses.”).
6. See State Bar of N.M. Ethics Advisory Comm., Formal Op. 2016-01, http://www.nmbar.org/
nmbardocs/formembers/eao/2016-01.pdf.
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parameters of what constitutes “assistance” under New Mexico’s Rule 16-102(D)7
are unclear.8 This uncertainty can chill the emerging business and legal market.9
The problem of medical marijuana and legal ethics reveals a far more
fundamental challenge. What are attorneys to do when their obligations to their
clients conflict with their obligations to the law? How are state ethics systems
expected to manage conflicting obligations to state and federal law? Legal ethics and
medical marijuana are catalysts for discussing these pervasive problems. This article
explores these ethical conundrums in the unique context of New Mexico’s medical
marijuana regulatory regime.
Part I of this article will establish the background of medical marijuana
regulation in New Mexico, including an explanation of the regulatory regime and a
brief overview of the applicable rules of legal ethics. This section will also highlight
the legal challenges facing medical marijuana producers and attorneys who desire to
assist them. In Part II, this article will offer and apply a framework for approaching
the legal ethics of medical marijuana representation in New Mexico. The analysis
will begin with an explanation of the New Mexico advisory ethics opinion on
medical marijuana representation. The ethics advisory opinion left more questions
than it answered and did not systematically analyze the problem. To create a more
coherent and consistent framework, the analysis will distill and synthesize principles
in different ethics advisory opinions selected from across the country. The interplay
between federalism and the state-controlled attorney discipline system will be crucial
to understanding the varying ethics advisory opinions. Then the analysis will turn to
New Mexico and apply the new framework to New Mexico’s unique legal
environment. Applying the framework, New Mexico should reconsider its approach
to the problem of medical marijuana legal ethics. The conclusion argues that the most
appropriate course of action for New Mexico is to refrain from disciplining lawyers
who assist medical marijuana businesses in effectuating New Mexico law.
PART I: BACKGROUND
The medical marijuana regulatory regime spans both state and federal law.
Federal law criminalizes marijuana, regardless of whether it is used medicinally or
recreationally.10 Some state laws allow for medical marijuana, but implement a
regulatory regime to ensure medicinal use.11 Other states, like Colorado, allow
marijuana use for any purpose.12 The ABA Model Rules of Professional Conduct

7. See Rule 16-102(D) NMRA (“A lawyer shall not counsel a client to engage, or assist a client, in
conduct that the lawyer knows is criminal or fraudulent or misleads the tribunal.”).
8. See N.M. Formal Op. 2016-01 (“The Committee is unable to agree as to the exact parameters of
‘assistance.’”).
9. See Lorelei Laird, Do Ethics Rules Allow Lawyers to Advise Clients on New Laws Legalizing
Marijuana?, A.B.A. J. (June 1, 2014, 8:40 AM), http://www.abajournal.com/magazine/article/do_ethics_
rules_allow_lawyers_to_advise_clients_on_new_marijuana_laws (“But there are concerns that, without
formal changes in the ethics rules, attorneys will be reluctant to take on clients in the emerging marijuana
industry”); see also Chemerinsky et al., supra note 1, at 97.
10. See Controlled Substances Act, 21 U.S.C. §§ 841, 844 (2012) (listing criminal penalties).
11. See, e.g., N.M. STAT. ANN. §§ 26-2B-1 to -7 (2009) (Lynn and Erin Compassionate Use Act).
12. See, e.g., COLO. CONST. art. XVIII, § 16.
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guide discussion of legal ethics, but states codes of ethics govern attorney
discipline.13
A.

Controlled Substances Act and Federal Law

The Controlled Substances Act currently criminalizes all use of
marijuana.14 Marijuana is a “Schedule I” controlled substance.15 Congress views
Schedule I substances as substances which have “no currently accepted medical use
in treatment in the United States.”16 While the federal law is still on the books, the
enforcement priorities of the Justice Department under the Trump administration
remain uncertain.17 Under the Obama administration, it was not a federal priority to
enforce the law against state-legal medical marijuana businesses.18 The Justice
Department “Cole Memorandum” stated that federal priorities were unlikely to be
threatened by states that legalize marijuana under a tightly regulated scheme.19 The
memorandum urged prosecutorial discretion, but also cautioned that large-scale
operations or for-profit marijuana businesses may interfere with federal enforcement
priorities.20 Congress may have effectively endorsed the policy when it passed a
spending bill with a provision that restricted federal funds used for enforcement of
federal drug laws against state-legal medical marijuana businesses.21 The federal
government’s enforcement policy is largely dependent upon the president’s policy
and may change with the Trump administration.22 However, the enforcement
objectives of the Justice Department under the Trump administration may not differ
much from objectives under the preceding administration.23

13. See GEOFFREY C. HAZARD, JR., W. WILLIAM HODES, & PETER R. JARVIS, THE LAW OF
LAWYERING § 1.17 (4th ed. 2016).
14. See Controlled Substances Act § 812 (listing “marihuana” as a Schedule I controlled substance);
see also id. §§ 841, 844 (listing criminal penalties).
15. Id. § 812(b)–(c).
16. See id. § 812(b)(1)(B).
17. See Memorandum from Jefferson B. Sessions, Att’y Gen., U.S. Dep’t Justice, to Head of Dep’t
Component U.S. Atty’s (April 5, 2017), https://www.justice.gov/opa/press-release/file/955476/download
(stating that existing policies concerning marijuana will be reviewed).
18. See Memorandum from James M. Cole, Deputy Att’y Gen., U.S. Dep’t Justice, to all U.S. Att’ys
(Aug. 29, 2013), https://www.justice.gov/iso/opa/resources/3052013829132756857467.pdf.
19. See id.
20. See id.
21. See Russell Berman, Why Congress Gave in to Medical Marijuana, THE ATLANTIC (Dec. 17,
2014), http://www.theatlantic.com/politics/archive/2014/12/a-congressional-surrender-in-the-medicalmarijuana-fight/383856/. However, not all commentators interpret the bill the same way. See Jacob
Sullum, Congress Did Not Legalize Medical Marijuana, FORBES (Dec. 31, 2015, 8:15 AM),
http://www.forbes.com/sites/jacobsullum/2015/12/31/congress-did-not-legalize-medical-marijuana/#35f
c258d715c.
22. See Jeremy Berke, The Trump Administration Doesn’t Appear to be Slowing Investment in the
Marijuana Industry, BUS. INSIDER (Feb. 9, 2017, 6:16 PM), http://www.businessinsider.com/marijuanaindustry-reactions-to-jeff-sessions-and-trump-administration-2017-2 (“[I]t remains to be seen how Trump
and [Attorney General] Sessions will handle marijuana . . . “).
23. Compare Memorandum from Jefferson B. Sessions, Att’y Gen., U.S. Dep’t Justice, to Head of
Dep’t Component U.S. Atty’s (April 5, 2017), https://www.justice.gov/opa/press-release/file/955476/
download (emphasizing control of violent crime as a primary objective) with Memorandum from James
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New Mexico Regulatory Scheme

The legal use of medical cannabis in New Mexico is based on the Lynn and
Erin Compassionate Use Act (the Act).24 Under the Act, qualified patients25 who are
diagnosed with debilitating medical conditions26 are allowed to use cannabis for
medical purposes and are not subject to civil or criminal penalty based on that use.27
The Act affords similar protections to licensed producers,28 medical practitioners,29
and primary caregivers of a patient.30 The Act also protects property interests
connected with medical cannabis from destruction, damage, or forfeiture caused by
state officials.31
At the core of the New Mexico regulatory scheme is a licensing system.
The Act authorizes the New Mexico Department of Health (NMDOH) to promulgate
regulation of licenses for patients, caregivers, practitioners, and distributors.32 The
regulations divide eligible producers into two categories—qualified patients and
non-profit producers.33 Qualified patients are restricted to a maximum of four female
plants and up to twelve of a combination of male plants or seedlings.34 Patients are
also limited to an “adequate supply” of medical cannabis.35
The regulations regarding corporate entities are considerably more
complicated. First, corporate producers must be non-profit entities.36 The board of
directors for the corporate entity must have a minimum of five members—including
a medical provider (e.g. a licensed medical doctor, a registered nurse, or any of the
following: nurse practitioner, licensed practical nurse, physician assistant), and three
qualified patients under the Act.37 Corporate entities are limited to a combined total

M. Cole, Deputy Att’y Gen., U.S. Dep’t Justice, to all U.S. Att’ys (emphasizing control of violent crime
as one objective among many).
24. See N.M. STAT. ANN. §§ 26-2B-1 to -7 (2009).
25. Id. § 26-2B-3(G) (defining “qualified patient” as “a resident of New Mexico who has been
diagnosed by a practitioner as having a debilitating medical condition and has received written
certification and a registry identification card issued pursuant to the [Act].”).
26. Id. § 26-2B-3(B) (listing the qualifying medical conditions).
27. See id. § 26-2B-4(A).
28. See id. § 26-2B-4(F).
29. See id. § 26-2B-4(E). A “practitioner” is defined as “a person licensed in New Mexico to prescribe
and administer drugs that are subject to the Controlled Substances Act. . . . “ Id. § 26-2B-3(E).
30. See id. § 26-2B-4(B).
31. See id. § 26-2B-4(G).
32. See generally id. § 26-2B-7 (promulgating rules for licensing scheme).
33. See N.M. CODE R. § 7.34.4.8(A) (2015).
34. Id.
35. Id. An “adequate supply” is defined as the amount no more than reasonably necessary to ensure
uninterrupted availability over a 90-day period. See id. § 7.34.4.7(B).
36. See id. § 7.34.4.8(A)(2); see also id. § 7.34.4.7(OO) (defining “private entity” as “a private, nonprofit organization that applies to become or is licensed as a producer and distributor of cannabis,
concentrates, or cannabis-derived products.”). To be considered a non-profit entity by the New Mexico
Taxation and Revenue Department, a business must maintain non-profit status under Section 501(c) of
the United States Internal Revenue Code. See N.M. TAXATION AND REVENUE DEP’T, FYI-103 (2014),
http://realfile.tax.newmexico.gov/FYI-103%20-%20Information%20for%20Nonprofit%20
Organizations.pdf.
37. See § 7.34.4.8(I).
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of 450 female plants, male plants, and seedlings.38 Corporate producers may not
produce in excess of current patient needs and they may not offer sales or promotions
encouraging bulk purchases.39 Distribution plans must be submitted to and approved
by the NMDOH.40 Producers are generally allowed to use approved couriers to
distribute their product to the appropriate locations (e.g. to a patient directly, to
another licensed non-profit facility, or to a laboratory for testing).41 Corporate
producers are required to have their cannabis product tested by an approved
laboratory42 for microbiological testing,43 mycotoxin testing,44 solvent residue
testing (if produced through solvent extraction methods),45 testing for quantity of
THC and CBD,46 and any other testing deemed appropriate by NMDOH.47 Use of
pesticide for producers is governed by the New Mexico Pesticide Control Act.48
The licensing scheme for non-profit producers requires a fair amount of
capital. The application fee for producers is ten-thousand dollars with a ninethousand-dollar refund if the application is denied.49 A license for plants begins at
thirty-thousand dollars for the first 150 plants and an additional ten-thousand dollars
for every fifty plants after that (to a maximum of 450 plants).50 The non-profit
businesses need capital to operate, so many affiliate with for-profit management
companies.51 Some argue that New Mexico’s non-profit requirement has become
“window dressing” for an industry largely managed by for-profit management
companies.52
As of the third quarter of 2016, 76,732 patients made purchases of medical
marijuana.53 There were over 11,000 plants in production that produced over a

38. See id. § 7.34.4.8(A)(2).
39. See id.
40. See id. § 7.34.4.8(E).
41. See id.
42. See id. § 7.34.4.9.
43. Id. § 7.34.4.9(C)(1) (requiring testing for microbiological contaminants).
44. Id. § 7.34.4.9(C)(2) (requiring testing for mycotoxin).
45. Id. § 7.34.4.9(C)(3) (requiring solvent residue testing).
46. Id. § 7.34.4.9(C)(5) (requiring testing for quantity of THC). THC stands for
tetrahydrocannabinol, which is the principal psychoactive constituent of cannabis. See Drug and Human
Performance Fact Sheets: Cannabis/Marijuana, NAT’L HIGHWAY TRAFFIC SAFETY ADMIN.,
https://one.nhtsa.gov/people/injury/research/job185drugs/cannabis.htm (last visited Feb. 19, 2017). CBD
is cannabidiol which is a chemical with a wide scope of medical applications. See Debra Borchardt, The
Cannabis Market That Could Grow 700% by 2020, FORBES (Dec. 12, 2016, 12:52 PM),
http://www.forbes.com/sites/debraborchardt/2016/12/12/the-cannabis-market-that-could-grow-700-by2020/#7b12c7a471ed.
47. § 7.34.4.9(C)(6).
48. Id. § 7.34.4.11.
49. Id. § 7.34.4.8(V)(1).
50. Id. § 7.34.4.8(V)(2).
51. See Olivier Uyttebrouck, Budding Operation: NM’s Nonprofit Medical Marijuana Takes ‘Big
Business” Turn, ALBUQUERQUE J. (Feb. 13, 2016, 11:45 PM), https://www.abqjournal.com/723600/notrue-nonprofits-in-pot-business.html.
52. Id.
53. See Memorandum from Kenny Vigil, Med. Cannabis Program Dir., N.M. Dep’t of Health, to
Licensed Non-Profit Producers (Nov. 10, 2016), https://nmhealth.org/publication/view/report/3135/.
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million units of medical marijuana.54 Reportedly, producers also gave patients over
30,000 units free of charge.55 Information about income and compensation was
unavailable in the report for the third quarter of 2016.56 In the second quarter of 2016,
total income exceeded 11.5 million dollars.57 The salary and other compensation (for
non-profit employees, etc.) amounted to over three million dollars.58 As of January
30, 2017, there are currently fifty-two licensed non-profit producers in New
Mexico.59
C.

New Mexico Rules of Professional Conduct and Model Rules

The New Mexico Rules of Professional Conduct limit the ability of
attorneys to serve the legal needs of medical marijuana businesses. New Mexico’s
Rule 16-102 states a lawyer “shall not counsel a client to engage, or assist a client,
in conduct that the lawyer knows is criminal or fraudulent or misleads the tribunal.”60
The New Mexico rule differs from the model rules in that it emphasizes the
importance of honesty to the tribunal.61 Since possession, distribution, and
production of marijuana are illegal under federal law,62 attorneys must be careful not
to “assist” or “counsel a client to engage” in such conduct.
Medical marijuana representation also implicates other rules of ethics. New
Mexico Rule 16-803 requires that lawyers who know of misconduct (e.g.
“assistance” of medical marijuana businesses) to report it to the New Mexico
Disciplinary Board.63 New Mexico attorneys may be disciplined for their assistance
of medical marijuana businesses even if such assistance occurs outside New
Mexico.64 Attorneys must not violate or attempt to violate the rules of ethics.65 Nor
should attorneys engage in criminal conduct that reflects adversely on their ability to
practice law or conduct that is “prejudicial to the administration of justice.”66 For
example, interference with the federal enforcement objectives regarding medical
marijuana could be considered “prejudicial to the administration of justice.” Despite
these complications, the New Mexico Rules of Professional Conduct emphasize that

54. See id.
55. See id.
56. See id.
57. See Memorandum from Ken Groggel, Med. Cannabis Program Manager, N.M. Dep’t of Health,
to Licensed Non-Profit Producers (Aug 23, 2016), https://nmhealth.org/publication/view/report/3081/.
58. See id.
59. See N.M. DEP’T OF HEALTH, LICENSED NONPROFIT PRODUCERS (2017), https://nmhealth.org/
publication/view/general/2101/.
60. See Rule 16-102(D) NMRA; see also MODEL RULES OF PROF’L CONDUCT r. 1.2(d) (AM. BAR
ASS’N 2016).
61. Compare Rule 16-102(D) NMRA with r. 1.2(d).
62. See Controlled Substances Act, 21 U.S.C. §§ 841, 844 (2012).
63. See Rule 16-803 NMRA; see also MODEL RULES OF PROF’L CONDUCT r. 8.3(a) (AM. BAR ASS’N
2016).
64. See Rule 16-805 NMRA.
65. See Rule 16-804(A) NMRA; see also MODEL RULES OF PROF’L CONDUCT r. 8.4(a) (AM. BAR
ASS’N 2016).
66. Rule 16-804(D) NMRA.
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the ethical rules are “rules of reason.”67 Given the complex state regulatory
framework, the vast array of legal issues facing non-profit producers, and the rules
of ethics, medical marijuana representation is a minefield for practicing attorneys.
Despite the ethical minefield, there has not yet been a recorded case of attorney
discipline for engaging in “assistance” of legal medical marijuana businesses.68
PART II: A FRAMEWORK FOR ANALYZING THE MEDICAL
MARIJUANA ETHICS CONUNDRUM
Practicing attorneys in New Mexico remain in a legal-ethics limbo. Medical
marijuana businesses need representation, but the legal ethics are uncertain at best
and prohibitive at worst. Different states have taken different approaches to the
ethical conundrum of legal representation for medical marijuana businesses. Each
different approach offers a key to building a more consistent framework for
analyzing the medical marijuana ethics problem. More broadly, such a framework is
useful for approaching the ethics of attorney representation in other areas of the law
where state and federal law conflict.
A.

New Mexico Approach

Medical marijuana, while legal under state law,69 is illegal under federal
law. An ethics advisory opinion71 released in summer 2016 concluded that lawyers
may not “assist” medical marijuana businesses, but lawyers may advise clients on
the implications of federal law and state law.72 The State Bar of New Mexico Ethics
Advisory Committee (“the Committee”) examined a number of different approaches
from other states for guidance.73 The Committee interpreted the Arizona State Bar
ethics opinion,74 which allowed attorney assistance of medical marijuana businesses,
to hinge upon the lack of federal enforcement, the lack of preemption of state law,
and public policy concerns.75 The Committee also examined the ethics opinion of the
State Bar of Maine.76 The Committee interpreted the Maine opinion to apply a strict
reading of the rules—regardless of whether the federal law is enforced, it is still
unethical for a lawyer to assist in conduct prohibited by federal law.77
70

67. Scope NMRA.
68. See Wagemaker, supra note 3, at 391.
69. See N.M. STAT. ANN. §§ 26-2B-1 to -7 (2009) (Lynn and Erin Compassionate Use Act).
70. See Controlled Substances Act, 21 U.S.C. §§ 841, 844 (2012).
71. State Bar of N.M. Ethics Advisory Comm., Formal Op. 2016-01, http://www.nmbar.org/
nmbardocs/formembers/eao/2016-01.pdf.
72. See id.
73. See id. (analyzing ethics opinions from Arizona and Maine).
74. State Bar of Ariz. Comm. on the Rules of Prof’l Conduct, Op. 11-01 (2011), http://www.azbar.org
/Ethics/EthicsOpinions/ViewEthicsOpinion?id=710.
75. See N.M. Formal Op. 2016-01; see also Ariz. Op. 11-01; Memorandum from David W. Ogden,
Deputy Att’y General, Dep’t of Justice, to Selected U.S. Att’ys (Oct. 19, 2009),
https://www.justice.gov/opa/blog/memorandum-selected-united-state-attorneys-investigations-andprosecutions-states.
76. See N.M. Formal Op. 2016-01; see also Me. Bd. of Overseers of the Bar Prof’l Ethics Comm.,
Op. 199 (2010), http://www.mebaroverseers.org/attorney_services/opinion.html?id=110134.
77. See N.M. Formal Op. 2016-01.
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The Committee sided with the reasoning of the Maine approach over the
Arizona approach.78 The Committee reasoned that the justifications of the Arizona
opinion were insufficient to overcome the fundamental illegality of marijuana under
federal law.79 The Committee determined that lawyers may not “engage in” or
“assist” medical marijuana businesses because their operations, which include the
production and distribution of controlled substances,80 violate federal law.81
However, the Committee could not reach a conclusion as to the scope of
“assistance.”82 The Committee generally came to the agreement, without much
analysis, that acts like negotiating contracts for the purchase of cannabis were
impermissible “assistance.”83 Other Committee members thought it might be
permissible to form a business organization for a client, even if it was used to produce
and distribute medical marijuana.84 The Committee suggested that lawyers should
decide how the word “assistance” applies to their situation, bearing in mind that the
boundaries of such assistance may be tested by an ethics complaint.85
There are two flaws with the Committee opinion. First, the Committee
offered an incomplete analysis. In accepting the reasoning of the Maine opinion, the
Committee did not consider other perspectives. The analysis stopped at the
determination that marijuana is still illegal under federal law and the rules of ethics
do not allow facilitation of criminal conduct. The opinion did not explore the policy
ramifications of the declaration, nor did it substantively consider alternate
justifications. To make informed decisions about legal ethics, it is important to have
a broad perspective. The forthcoming analysis will provide a broader perspective.
The second flaw in the Committee’s opinion is the failure to outline the
contours of “assistance” under the rules of ethics. The New Mexico rules do not
define the word “assistance” and the committee commentary does not further
elaborate on the scope of “assistance” either.86 The refusal to commit to a firmer
scope of “assistance” leaves uncertainty for practicing lawyers. The Committee’s
suggestion that the scope of “assistance” should be decided by attorneys or tested by
an ethics complaint is an untenable proposition for attorneys who wish avoid
disciplinary proceedings. These two flaws in the Committee’s opinion can be
mended by a closer examination of the rules of ethics and the ethics opinions of other
states.
B.

Approaches of Other States

There are two basic approaches that states have taken to the ethics
conundrum presented by medical marijuana laws. One group of states, including
Maine, Colorado, Ohio, and New Mexico, believe lawyers may not assist medical

78.
79.
80.
81.
82.
83.
84.
85.
86.

See id.
See id.
See Controlled Substances Act, 21 U.S.C. § 841 (2012).
See N.M. Formal Op. 2016-01.
Id.
See id.
See id.
See id.
See Rule 16-100 NMRA; Rule 16-102(D) NMRA.
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marijuana businesses outside of giving advice as to the legality or illegality of their
conduct. Within these opinions there is a varying spectrum of what each state
believes is permissible, but they are all in general agreement that lawyers may not
assist medical marijuana businesses. Another group of states, including Arizona and
New York, believes that lawyers are permitted to assist medical marijuana businesses
pursuant to state law. The opinions of Arizona and Colorado are especially relevant
to New Mexico as they are neighboring states and their determinations may affect
legal entities in New Mexico.87
(1) Assistance is Permitted (Arizona, New York, and Washington)
The ethics advisory opinion of the Arizona State Bar determined that
assistance of medical marijuana businesses, pursuant to state law, does not violate
the Arizona Rules of Professional Conduct.88 The opinion was based on three key
findings. First, the opinion sidestepped concerns about lawyers that “counsel a client
to engage, or assist a client, in conduct that the lawyer knows is criminal or
fraudulent”89 by pointing out that current federal law enforcement practices do not
pursue conduct that is in “clear and unambiguous compliance” with state law.90
Second, the Arizona opinion relied heavily on public policy concerns. For example,
the opinion stated, “[t]he maintenance of an independent legal profession, and of its
right to advocate for the interests of clients, is a bulwark of our system of
government. . . . Legal services are necessary or desirable to implement and bring to
fruition that conduct expressly permitted under state law.”91 Third, the opinion relied
on principles of federalism. The Arizona Committee concluded that the opinion was
contingent upon a lack of federal preemption and a lack of federal enforcement—a
change in either one could change the conclusion.92 The opinion also pointed out that
Arizona ethics decisions have condemned lawyers who knowingly violate or assist
in violating state law, but pointed out that there were no determinations concerning
lawyer conduct in a conflict-of-laws situation.93
Other states have taken approaches similar to Arizona, although there are
differences. The King County Bar Association (KCBA) in Washington state offered

87. See, e.g., Peter St. Cyr, Growing Pains: How Money Flows from a Nonprofit Cannabis Producer
in Santa Fe to a For-Profit Arizona Company, SANTA FE REP. (Apr. 6, 2016, 12:00 AM),
http://www.sfreporter.com/santafe/article-11802-growing-pains.html (discussing one New Mexico
cannabis producer’s business dealings with an Arizona for-profit company). Arizona and Colorado are
particularly important for understanding the ethics problem because businesses may be able to obtain legal
advice from out-of-state attorneys or through affiliated management companies, circumventing New
Mexico legal ethics. Cf. Eric Mitchell Schumann, Clearing the Smoke: The Ethics of Multistate Legal
Practice for Recreational Marijuana Dispensaries, 6 ST. MARY’S J. ON LEGAL MALPRACTICE & ETHICS
332, 357–58 (2016) (discussing the issue of attorneys being subject to discipline for violating rules of
professional conduct in another jurisdiction).
88. See State Bar of Ariz. Comm. on the Rules of Prof’l Conduct, Op. 11-01 (2011),
http://www.azbar.org/Ethics/EthicsOpinions/ViewEthicsOpinion?id=710.
89. ARIZ. RULES OF PROF’L CONDUCT ER. 1.2(d) (2016).
90. Ariz. Op. 11-01 (quoting Memorandum from David W. Ogden to Selected U.S. Att’ys, supra
note 75).
91. Id.
92. See id.
93. See id.
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an ethics advisory opinion that differed from the Arizona opinion in several notable
respects. The KCBA opinion, more than the Arizona opinion, based its rationale on
principles of effectuating state law. The KCBA opinion noted the legal complexity
of the new regulations and the need for lawyers to effectuate state action.94 The
opinion asserted that, “[i]n building this complex system, the voters of Washington
could not have envisioned it working without attorneys.”95 The reasoning of the
KCBA opinion demonstrates the deference given not only to the state legislature, but
also the voters who approved the regulation. The KCBA opinion also rejected the
Arizona opinion’s reliance on the fact that the Arizona law had not been preempted.96
The KCBA found the lack of preemption largely irrelevant because federal law still
enjoys full force throughout Arizona regardless of state law—in other words, state
law does not weaken federal law.97 The KCBA also pointed out that attorney
discipline is a state-based regime and should be interpreted to give force to state
law.98 The opinion argued that the state has “no legitimate interest in disciplining
attorneys who operate within the confines of [the regulatory regime].”99
The New York State Bar Association added different dimensions to the
analysis. The New York Bar concluded that lawyers may provide legal assistance
beyond merely discussing the legality of the client’s conduct.100 In its analysis, the
New York opinion drew attention to Rule 8.4(b)101 which states that a lawyer shall
not “engage in illegal conduct that adversely reflects on the lawyer’s honesty,
trustworthiness or fitness as a lawyer.”102 The New York opinion found that attorney
conduct in furtherance of the state medical marijuana regime did not reflect adversely
on the attorney’s honesty, trustworthiness, or fitness as a lawyer.103 Unlike the other
ethics opinions, the New York opinion made a distinction that the legal assistance in
furtherance of the state’s medical marijuana act was not intended “to escape law
enforcement by avoiding detection.”104 Like the other opinions, the New York
opinion emphasized the importance of effectuating state law,105 that state ethics rules

94. See King Cty. Bar Ass’n, KCBA Ethics Advisory Op. on I-502 & Rules of Prof’l Conduct (2013),
http://www.kcba.org/judicial/legislative/pdf/i502_ethics_advisory_opinion_october_2013.pdf.
95. Id.
96. Id. at n.17.
97. Id. This may be based on a misinterpretation of the Arizona opinion. The KCBA opinion seems
to interpret the Arizona opinion to mean that the Arizona statute weakens federal law. The Arizona opinion
asserts that if the Arizona law were invalidated or preempted there may be no legitimate basis for lawyers
to assist medical marijuana producers. In other words, there would be no legitimate state law for lawyers
to effectuate. See Ariz. Op. 11-01.
98. See KCBA Ethics Advisory Op. on I-502 & Rules of Prof’l Conduct.
99. Id.
100. N.Y. State Bar Ass’n Comm. on Prof’l Ethics, Op. 1024 (2014), http://www.nysba.org/Custom
Templates/Content.aspx?id=52179.
101. Id.
102. N.Y. RULES OF PROF’L CONDUCT r. 8.4(b) (2013); see also Rule 16-804(B) NMRA; MODEL
RULES OF PROF’L CONDUCT r. 8.4(b) (AM. BAR ASS’N 2016).
103. See N.Y. Op. 1024 at n.8.
104. Id.
105. See id. (“Nothing in the history and tradition of the profession, in court opinions, or elsewhere,
suggests that Rule 1.2(d) was intended to prevent lawyers in a situation like this from providing assistance
that is necessary to implement state law and to effectuate current federal policy.”).
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should be construed to promote effective interpretation of state law,106 and that the
federal lack of enforcement bears upon whether assistance is ethically permissible.107
(2) Assistance is Not Permitted
In 2010, the Maine Bar Association concluded that attorney assistance of
medical marijuana businesses is ethically impermissible.108 The opinion states that
“the Rule which governs attorney conduct does not make a distinction between
crimes which are enforced and those which are not.”109 The opinion did not
substantively analyze the public policy arguments for allowing lawyers to assist
medical marijuana businesses.110 The opinion, on the contrary, suggested that clients
may use the guise of state law for “more lucrative ventures.”111 The Maine Bar
Association opined differently in 2016. On May 4, 2016, the Maine Bar Association
released another advisory ethics opinion that endorsed a different approach.112 The
commission stated that they revisited the opinion “to offer additional guidance to
individuals and entities seeking legal advice to assist them in navigating the statutory
and regulatory structure posed by the Maine legislation.”113 The 2016 opinion
considered a number of states that have carved exceptions in their rules of
professional conduct for lawyers who assist medical marijuana businesses pursuant
to state law.114 Without much reasoning, the Maine Bar Association recommended
an amendment to the Maine Rules of Professional Conduct to allow attorney
assistance of medical marijuana businesses.115 The 2016 opinion still included a
caveat that the opinion may change if federal enforcement policy changes.116
Ohio has taken a hardline approach to the ethics of assisting medical
marijuana businesses. The Ohio opinion’s analysis did not extend far beyond the fact
that marijuana is illegal under federal law and lawyers may not knowingly assist
illegal conduct.117 The Ohio opinion emphasized that Rule 1.2118 “embodies a
lawyer’s important role in promoting compliance with the law by providing legal

106. See id. (“In general, state professional conduct rules should be interpreted to promote state law,
not to impede its effective implementation.”).
107. See id. (“In light of current federal enforcement policy, the New York Rules of Professional
Conduct permit a lawyer to assist a client in conduct designed to comply with state medical marijuana
law . . . ”).
108. Me. Bd. of Overseers of the Bar Prof’l Ethics Comm., Op. 199 (2010),
http://www.mebaroverseers.org/attorney_services/opinion.html?id=110134.
109. Id.
110. See id.
111. Id. This concern mirrors the concerns presented in the 2009 Department of Justice memorandum
on medical marijuana enforcement. See Memorandum from David W. Ogden to Selected U.S. Att’ys,
supra note 75.
112. See Me. Bd. of Overseers of the Bar Prof’l Ethics Comm., Op. 214 (2016),
http://www.mebaroverseers.org/attorney_services/opinion.html?id=683190.
113. Id.
114. See id.
115. See id.
116. See id.
117. See Supreme Court of Ohio Bd. of Prof’l Conduct, Op. 2016-6, https://www.supremecourt.
ohio.gov/Boards/BOC/Advisory_Opinions/2016/Op_16-006.pdf.
118. OHIO RULES OF PROF’L CONDUCT r. 1.2(d)(1) (2016).
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advice and assistance in structuring clients’ conduct in accordance with the law.”119
The Ohio opinion laid out an extensive list of what constitutes impermissible
assistance. This list included negotiating contracts, corporate entity formation, and
even property transactions with medical marijuana businesses.120 The opinion stated
that the Supreme Court of Ohio may amend the rules to allow for the conduct.121 In
September 2016, the Ohio Rules of Professional Conduct were amended to include
an exception for assisting medical marijuana businesses.122
The State Bar of Colorado issued an advisory ethics opinion in 2013 that
discussed permissible activities as a “spectrum” of conduct.123 The opinion stated
that lawyers may assist clients in dealing with past activities and lawyers may advise
clients as to the legal implications of their actions.124 The opinion acknowledged that
the plain language of the rule would forbid lawyers from assisting medical marijuana
businesses with conduct illegal under federal law.125 The Colorado opinion
recognized the public policy benefits noting that “[l]aw-abiding people can go
nowhere else to learn the ever changing and constantly multiplying rules by which
they must behave and to obtain redress for their wrongs.”126 Nevertheless, the
Colorado opinion noted that the plain language of the rule prohibited assistance.127
Colorado eventually adopted an amendment to their rules of professional conduct
that permits lawyer assistance of marijuana businesses.128
C.

Framework for Analyzing the Ethics Problem

This framework begins with the presumption that attorney ethics should be
tailored to a specific state’s public policy. Each state has its own code of professional
conduct. State codes often differ, at least in some respect, from the model ABA
rules.129 Legal ethics is not a one-size-fits-all endeavor. Each state has its own history
of attorney discipline that provides insight into the contours of what that state values
in terms of attorney ethics.
Attorney discipline is a state-based system.130 Regulation of lawyers has
historically been state-based, and basic regulations (such as admittance to the bar)

119. Ohio Op. 2016-6.
120. See id.
121. See id.
122. OHIO RULES OF PROF’L CONDUCT r. 1.2(d)(2) (2016).
123. Colo. Bar Ass’n Ethics Comm., Formal Op. 125 (2013), http://www.cba.cobar.org
/tcl/tcl_articles.cfm?articleid=8370.
124. See id.
125. See id.
126. Id. (quoting Hickman v. Taylor, 329 U.S. 495, 515 (1947) (Jackson, J., concurring)).
127. See id.
128. See COLO. RULES OF PROF’L CONDUCT r. 1.2 cmt. 14 (2016). The Colorado federal courts
declined to adopt comment 14 and continue to emphasize that lawyers may not assist marijuana
businesses. D.C.COLO.L.ATT’Y R. 2(b)(2) (2014).
129. See, e.g., Rule 16-102(D) NMRA (differing from the Model Rules of Professional Conduct in its
requirement to avoid counseling clients to engage in conduct that will mislead the tribunal).
130. See HAZARD, supra note 13 (“The development and legalization of rules of professional
conduct . . . has been a story that was largely played out at the state level.”).
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have been state-controlled.131 Federal courts and agencies necessarily play a
“secondary role” in the regulation of lawyers.132 Federal courts generally borrow
from state codes of conduct and abide by state court guidelines for admission to the
bar.133 While federal courts have inherent power to discipline attorneys, courts
generally borrow from state codes of conduct in making their determinations.134
Given the state-based nature of attorney discipline, it is unusual that many states
chose to defer to federal law to determine their application of attorney discipline.135
When state law conflicts with federal law, the states still have the power to
choose how to apply their codes of ethics to attorneys. In the case of medical
marijuana, the ethics opinions of different states have implicitly laid out several
factors when interpreting their code of professional conduct: (1) the role of the
attorney in the legal system; (2) level of conflict with federal law; (3) public policy
concerns, including the practical need for attorney assistance to effectuate state law.
Applying these factors is a more comprehensive and systematic approach for
analyzing the ethics problem.
The first factor is the role of the attorney in the legal system. How a
particular jurisdiction views the role of an attorney is crucial to interpreting the
jurisdiction’s rules of professional conduct. The ethics opinions emphasized two
different viewpoints on the role of an attorney. One viewpoint emphasized that
attorneys must uphold the law.136 This classic viewpoint aims to maintain public faith
in lawyers and the legal system.137 Another viewpoint asserts that the role of
attorneys is to effectuate the laws of the state.138 The goal here is to ensure public
confidence in lawyers and the legal system by ensuring that attorneys help the public
navigate the laws that they have created.139 It is possible to hold both viewpoints, but
acknowledge that one holds more importance than the other.140 The ethics culture in

131. See id.
132. Id.
133. See id.
134. See id.
135. Several states eventually amended their rules of professional conduct in response. See, e.g.,
COLO. RULES OF PROF’L CONDUCT r. 1.2 cmt. 14 (2016). New Mexico presents a peculiar problem
because the New Mexico Supreme Court rejected an amendment to the Rules of Professional Conduct
that would have allowed attorney assistance of medical marijuana businesses pursuant to the
Compassionate Use Act. See State Bar of N.M. Ethics Advisory Comm., Formal Op. 2016-01 n.1,
http://www.nmbar.org/nmbardocs/formembers/eao/2016-01.pdf.
136. See, e.g., Supreme Court of Ohio Bd. of Prof’l Conduct, Op. 2016-6,
https://www.supremecourt.ohio.gov/Boards/BOC/Advisory_Opinions/2016/Op_16-006.pdf.
137. See, e.g., In re Key, 2005-NMSC-014, ¶ 8, 113 P.3d 340 (“The public cannot be expected to have
respect for our system of justice if we permit the officers of our courts to violate the very laws they are
sworn to uphold and upon which they advise and counsel others to comply.” (quoting In re Cox, 1994NMSC-054, ¶ 8, 874 P.2d 783)).
138. See, e.g., State Bar of Ariz. Comm. on the Rules of Prof’l Conduct, Op. 11-01 (2011),
http://www.azbar.org/Ethics/EthicsOpinions/ViewEthicsOpinion?id=710.
139. See, e.g., Colo. Bar Ass’n Ethics Comm., Formal Op. 125 (2013),
http://www.cba.cobar.org/tcl/tcl_articles.cfm?articleid=8370 (arguing that the public must be able to turn
to lawyers to understand the ever-shifting law).
140. See, e.g., King Cty. Bar Ass’n., KCBA Ethics Advisory Op. on I-502 & Rules of Prof’l Conduct
(2013),
http://www.kcba.org/judicial/legislative/pdf/i502_ethics_advisory_opinion_october_2013.pdf
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some jurisdictions may emphasize the importance of the rule of law, in which case
deference must be given to the federal law and the Controlled Substance Act.
However, if a jurisdiction finds the need for legal guidance more compelling then
respecting the federal law may be less important. It is possible to promote both goals,
but at some point they become mutually exclusive when it comes to the ethics of
medical marijuana representation.
The second factor to consider is the level of conflict with federal law. Two
fundamental goals of attorney ethics are to maintain public confidence in the legal
system and to protect the public.141 If attorneys are allowed to openly defy federal
law, such actions may undermine public confidence in the rule of law. However, if
there is little conflict with federal law then there may be minimal damage to public
confidence in the legal system. Several of the ethics opinions implied that the reason
they permitted assistance of medical marijuana businesses was because the actual
conflict with federal law is minimal.142 The Arizona opinion noted that there was no
preemption of the state law—assistance of medical marijuana businesses was
permissible because there is a legitimate state law, which lawyers can effectuate.143
Unless federal policy changes, the federal government does not strictly enforce the
law against medical marijuana businesses operating in the bounds of state law.144
The Cole Memorandum noted that federal enforcement priorities concern violence
in the marijuana business and large, interstate, for-profit operations.145 Congress also
passed a spending bill with an amendment that restricted the use of federal funds for
enforcement of the federal ban on growing or selling marijuana in states that have
legalized medical marijuana.146 The position of the federal judiciary may vary, but
in Colorado the district courts disapproved of assistance of medical marijuana
businesses.147 This information is all useful to consider when applying the second
factor.
The third and final factor is public policy concerns. If the rules of attorney
ethics create absurd scenarios, frustrate the public, or impede the growth of business,
such outcomes certainly will not help the administration of justice or public
confidence in the legal system. It has already been acknowledged that application of
the ethics rules may limit access to attorneys.148 People have already suffered adverse
legal outcomes because of the conflict between state and federal law.149 Attorney
advice, or assistance, may have been able to better guide the parties. Disallowing
attorney assistance of medical marijuana businesses may ultimately reflect
(acknowledging that a plain reading of the rule of ethics forbids attorney assistance, but deciding to
ultimately allow such assistance).
141. See In re Key, 2005-NMSC-014, ¶ 8, 113 P.3d 340 (quoting In re Cox, 1994-NMSC-054, ¶ 8);
see also MODEL RULES OF PROF’L CONDUCT preamble (AM. BAR ASS’N 2016).
142. See, e.g., Ariz. Op. 11-01 (noting the current lack of federal enforcement and that the conclusion
may differ if the status quo changed).
143. See id.
144. See Memorandum from James M. Cole to all U.S. Att’ys, supra note 18.
145. See id. Federal enforcement priorities under the Trump administration may not be much different.
See Memorandum from Jefferson B. Sessions to Head of Dep’t Component U.S. Atty’s, supra note 17.
146. See Berman, supra note 21.
147. See D.C.COLO.LATT’Y R. 2(b)(2) (2014).
148. See Chemerinsky et al., supra note 1, at 97.
149. See id. at 96–97.
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negatively on the administration of justice and faith in the legal system. It is at least
another factor to consider when interpreting a jurisdiction’s rules of ethics.
A particular jurisdiction’s values can be inferred from their rules of ethics,
disciplinary decisions, and other factors. The following section will apply this
framework in the unique legal environment of New Mexico. In applying the
framework, the analysis will consider New Mexico’s disciplinary decisions, its rules
of professional conduct, and other relevant evidence.
D. Application to New Mexico
(1) Role of the Attorney
The New Mexico Supreme Court clearly stated its view on the role of
attorneys and attorney discipline in In re Key. The court stated, “the ultimate purpose
of attorney discipline is the protection of the public.”150 The court also noted that:
The purpose of attorney discipline is not solely to protect clients
from being harmed by their attorneys, but also to protect the
profession and the administration of justice. The public cannot be
expected to have respect for our system of justice if we permit the
officers of our courts to violate the very laws they are sworn to
uphold and upon which they advise and counsel others to
comply.151
The New Mexico Creed of Professional Conduct notes that attorneys swear
to “be mindful of [their] commitment to the public good” and “commit to the goals
of the legal profession . . . [their] responsibilities to public service, improvement of
administration of justice, [and] civic influence. . . . “152
Clearly, New Mexico exhibits a preference for the viewpoint that attorneys
must uphold the law. The Creed of Professionalism shows that New Mexico places
some value in the viewpoint that attorneys must effectuate the law. It is difficult to
overlook the clear statement in In re Key—New Mexico clearly gives more weight
to the viewpoint that attorneys must uphold the law.153
On the one hand, New Mexico courts imply that the very basis of the justice
system is the rule of law and that attorneys must abide by the laws they are sworn to
uphold. The underlying argument addresses public confidence in attorneys and the
justice system. Unfortunately, in this case, the laws that many state attorneys are
sworn to uphold are in conflict. Assisting businesses in compliance with state law
could promote, rather than undermine, “the administration of justice.” Assisting
clients in conduct that violates federal law may run contrary to the administration of
federal justice. To complicate matters, some attorneys may exclusively practice
federal law in New Mexico (e.g. federal tax law). It would be nonsensical to allow
attorneys who only practice under the federal bar to assist in violating federal law.
150. In re Key, 2005-NMSC-014, ¶ 8, 113 P.3d 340.
151. Id. (quoting In re Cox, 1994-NMSC-054, ¶ 8, 874 P.2d 783).
152. Creed of Professionalism, STATE BAR OF N.M., http://www.nmbar.org/Nmstatebar/For_
Members/Creed_of_Professionalism.aspx (last visited Feb. 28, 2017).
153. Cf. Rule 16-102(D) NMRA (demonstrating a value and respect for the rule of law by explicitly
forbidding conduct that misleads the tribunal).
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That would be a clear example of attorneys violating the laws they are sworn to
uphold.
Either approach has implications for public confidence in the legal system.
However, the New Mexico Supreme Court has expressed a clear preference for
upholding the rule of law. That means all laws, including federal law.154 This factor
weighs in favor of not allowing attorneys to assist medical marijuana businesses.
(2) Level of Conflict with Federal Law
The New Mexico medical marijuana regulatory regime minimally conflicts
with federal law. As noted earlier, the executive branch has redirected enforcement
away from tightly-regulated state medical marijuana systems.155 In addition,
Congress has limited enforcement against medical marijuana businesses.156 The
Justice Department memoranda laid out enforcement objectives which included
prevention of violence, restricting affiliated organized crime, and other objectives.157
The 2013 memorandum specifically cautioned against large, for-profit marijuana
businesses and suggested enforcement may occur against such entities.158 The New
Mexico scheme requires corporate marijuana producers to be non-profit entities.159
In addition, the New Mexico system is tightly regulated.160 New Mexico’s system
falls far away from violating the federal enforcement priorities. For-profit
management companies,161 and their affiliation with the New Mexico regulatory
scheme, may begin to threaten federal enforcement priorities. For the most part the
New Mexico system, and presumably lawyers who assist that system, may not
directly conflict with federal enforcement priorities.
Attorney assistance of medical marijuana businesses may violate federal
law, and thus violate the New Mexico rules of ethics.162 Considering the facts
mentioned above, it may be a technical violation of federal law. It is facially true that
the rules of ethics do not distinguish between laws that are enforced and laws that
are not enforced. But not all laws carry equal weight, and not all laws carry equal
weight regarding attorney discipline.163 For example, attorneys may “engage in” the
illegal conduct of driving over the speed limit. While a consistent pattern of such
disregard for the law may warrant discipline, such violations may go largely
untouched. In contrast, an attorney assisting in tax fraud is a much more serious issue
154. This inference is bolstered by the fact that the New Mexico Supreme Court rejected an
amendment to the New Mexico Rules of Professional Conduct which would allow representation of
marijuana businesses. See State Bar of N.M. Ethics Advisory Comm., Formal Op. 2016-01 n.1,
http://www.nmbar.org/nmbardocs/formembers/eao/2016-01.pdf.
155. See Memorandum from James M. Cole to all U.S. Att’ys, supra note 18; Memorandum from
David W. Ogden to Selected U.S. Att’ys, supra note 75.
156. See Berman, supra note 21.
157. See Memorandum from James M. Cole to all U.S. Att’ys, supra note 18.
158. See id.
159. See N.M. CODE R. § 7.34.4.8(A)(2) (2015).
160. See generally N.M. STAT. ANN. §§ 26-2B-1 to -7 (2007).
161. See generally Uyttebrouck, supra note 51 (describing the relationship between for-profit
companies and medical marijuana producers).
162. See Rule 16-102(D) NMRA.
163. See Comment 2 to Rule 16-804 NMRA (punishing criminal acts which reflect only on an
attorney’s fitness to practice law).
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that warrants more serious discipline.164 The rules of ethics do distinguish
seriousness of conduct for attorney discipline.165 New Mexico Rule 16-804 draws a
distinction between criminal misconduct and professional misconduct. Comment 2
on the rule states “[a]lthough a lawyer is personally answerable to the entire criminal
law, a lawyer should be professionally answerable only for offenses that indicate
lack of those characteristics relevant to law practice.”166 The principles of Rule 16804 can be applied to this situation.167 Attorneys may be engaging in conduct that
assists in violation of federal law, but that does not necessarily reflect adversely on
an attorney’s fitness to practice law. The federal enforcement apathy does not go to
the legality or illegality of the attorney assistance, but it does go to the seriousness
of such conduct.
The New Mexico Supreme Court’s disciplinary opinions tend to admonish
serious misconduct, especially concerning honesty and candor. New Mexico Rule
16-102(D) differs from the model rule in that it implores attorneys to avoid conduct
that is misleading to the tribunal.168 This emphasis is reflected in some of New
Mexico’s disciplinary decisions. For example, in In re Michele Estrada the court
admonished a lawyer that presented a forgery into evidence through lack of
diligence.169 The court emphasized the duty in New Mexico not to engage in conduct
that misleads the court.170 In the case of In re Chavez the court issued a public censure
and suspension, admonishing the dishonesty of a lawyer who engaged in a pattern of
misrepresentations to the court.171 The court stated:
[a]ttorneys are officers of the court, and our system of justice
works only if the courts can rely on attorneys to fulfill their duty
of candor to the tribunal. Respondent must fulfill his obligation to
exhibit the personal honesty and integrity expected of lawyers and
to refrain from dishonesty and other conduct prejudicial to the
administration of justice.172
Considering the New Mexico Supreme Court’s disciplinary decisions, the
federal enforcement climate, and the New Mexico regulatory scheme, lawyer
assistance of medical marijuana businesses may not be sufficiently serious to warrant
discipline. Lawyers intend to assist clients with conduct that is legal under state law.
This conduct generally would not involve assistance in avoiding federal criminal
liability, but rather it would involve complying with the complex state regulation. As
the New York ethics opinion notes, lawyers do not aim to conceal their conduct and

164. See, e.g., In re Key, 2005-NMSC-014, ¶¶ 8–9, 113 P.3d 340.
165. See Comment 2 to Rule 16-804 NMRA.
166. Id.
167. But see N.Y. State Bar Ass’n Comm. on Prof’l Ethics, Op. 1024 n.8 (2014),
http://www.nysba.org/CustomTemplates/Content.aspx?id=52179 (suggesting an analysis under Rule 8.4
is inapplicable).
168. Compare Rule 16-102(D) NMRA with MODEL RULES OF PROF’L CONDUCT r. 1.2(d) (2016).
169. In re Estrada, 2006-NMSC-047, ¶¶ 2–3, 143 P.3d 731.
170. See id. ¶ 22.
171. In re Chavez, 2013-NMSC-008, ¶¶ 1, 8, 299 P.3d 403.
172. Id. ¶ 26 (citation omitted).
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avoid federal law.173 This type of conduct does not implicate dishonesty or avoidance
of the law. It does not appear to be the serious type of conduct that the New Mexico
Supreme Court typically admonishes.174 This factor falls in favor of allowing
attorneys to assist medical marijuana businesses. However, this conclusion may
easily change if federal enforcement policy changes—in that case there may be a
greater conflict between state practice and federal law.
(3) Public Policy Concerns
The most compelling reason to allow lawyers in New Mexico to assist
medical marijuana businesses is public policy concerns. The Compassionate Use Act
is a complex legal instrument with an even more complex administrative scaffolding.
It is unreasonable to ask legitimate businesses to navigate these legal conundrums
without the assistance of an attorney. New Mexico’s administrative system makes
this argument particularly compelling. As per regulation, medical marijuana
businesses must operate as non-profit entities.175 There is a great public interest in
allowing attorneys to assist non-profit businesses that provide medicine to over
seventy-thousand patients176 in New Mexico.
Medical marijuana businesses may find legal representation anyway.177
Attorneys in New Mexico may affiliate with out-of-state attorneys who may ethically
perform the work New Mexico attorneys are unable to perform. This could drive
some legal business out of state. Some attorneys in New Mexico may assist clients
regardless of the dubious ethics. There is still a question of disciplinary enforcement.
Although the opinion is new, there have been no recorded cases in New Mexico of
disciplinary proceedings based on assisting medical marijuana businesses. In fact,
across the nation there have been no recorded cases of attorney discipline for
attorneys assisting medical marijuana businesses pursuant to state law.178
There is a significant potential for abuse in the reporting process. Medical
marijuana businesses touch upon property law, administrative law, tax law, business
transactions, contract law, and much more. Each attorney has the duty to report if
another attorney is violating the rules of professional conduct by “assisting” medical
marijuana businesses.179 Attorneys may also be reported for failing to report
misconduct.180 If out-of-state attorneys assist medical marijuana businesses in
complying with New Mexico law there could be accusations of unauthorized practice
of law.181 Depending upon an attorney’s level of involvement with medical

173. See N.Y. State Bar Ass’n Comm. on Prof’l Ethics, Op. 1024 (2014),
http://www.nysba.org/CustomTemplates/Content.aspx?id=52179.
174. This analysis is complicated by the fact that the New Mexico Supreme Court did not adopt a
proposed rule that would carve an exception in the rules of ethics for assistance of medical marijuana
businesses pursuant to state law. See State Bar of N.M. Ethics Advisory Comm., Formal Op. 2016-01 n.1,
http://www.nmbar.org/NmbarDocs/PubRes/BB/2016/BB_2016-08-10.pdf.
175. See N.M. CODE R. § 7.34.4.8(A)(2) (2015).
176. See Memorandum from Kenny Vigil to Licensed Non-Profit Producers, supra note 53.
177. See Schumann, supra note 87, at 357–58.
178. Id. at 355.
179. Cf. Rule 16-803(A) NMRA.
180. See Comment 3 to Rule 16-803(A) NMRA.
181. See Schumann, supra note 87, at 357–58.
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marijuana businesses, there also could be accusations that an attorney’s conduct is
“prejudicial to the administration of justice” in violation of Rule 16-804.182 There is
simultaneously a potential lack enforcement problem and the prospect of overzealous
enforcement.
Allowing assistance of medical marijuana businesses may spark its own
public policy concerns. Lawyers in New Mexico who primarily practice federal law
cannot be expected continually violate law in their sole area of practice. In Colorado,
the federal district courts did not adopt the amendment to the Colorado Rules of
Professional Conduct that allowed legal assistance of medical marijuana
businesses.183 Such conflict may undermine public confidence in the legal system.
This public policy concern has the potential to affect any lawyer who assists medical
marijuana businesses in both state courts and federal courts.184
The third factor of public policy concerns also falls in favor of New Mexico
permitting attorney assistance of medical marijuana businesses. The New Mexico
scheme is complex and it does not violate federal enforcement objectives. There is
significant policy interest in assisting medical marijuana businesses in providing
medicine for their patients. There are concerns regarding the encroaching for-profit
businesses and the potential conflict with the federal district court. However, these
concerns do not defeat the significant policy interest of effectuating New Mexico’s
state law.
CONCLUSION
When state and federal law conflict, states must decide how their system of
ethics will approach the problem. The best way for states to do this is to determine
how they view the role of attorneys, the level of conflict between state law and
federal law, and the overriding public policy concerns that inevitably arise from each
course of action. This systematic examination of ethics values and policy values
provides a coherent and consistent approach to the ethics conundrum. In the case of
New Mexico, the factors indicate that New Mexico should reconsider its current
approach. New Mexico values attorneys upholding the rule of law, including federal
drug law. However, New Mexico’s regulatory system for medical marijuana
minimally conflicts with federal law and there are substantial public policy
considerations in favor of allowing attorneys to assist medical marijuana businesses.
New Mexico should take a second look at its ethics advisory opinion, and it should
reconsider its current approach to the ethical conundrum.

182. See Rule 16-804(D) NMRA.
183. See D.C.COLO.L.ATT’Y R. 2(b)(2) (2014).
184. Commentators have suggested a cooperative federalism solution that would involve federal
guidelines for state regulatory schemes in exchange for immunity from federal enforcement. See generally
Chemerinsky et al., supra note 1. An analogous solution in the field of ethics may be worked out between
federal district courts and state regulators.

